In this press release, Reshma Kewalramani speaks on Vertex's expansion and $50 million commitment to creating a more equitable society.

In this Q&A with Barri Blauvelt, Reshma Kewalramani speaks on the ways that companies can work to make gender and diversity gaps smaller in STEM, as well as Vertex's solutions to promoting diversity and investing into the next generation of scientists.

Reshma Kewalramani discusses the findings behind from research into a pain relieving medicine that’s an alternative to opioids and more related topics.

Dr. Kewalramani will join the Board of Directors for Ginkgo Bioworks, Inc. after she has been recognized for her work in innovating the pharmaceutical industry.